The dermadiagnostics mission is to provide a non-invasive dermal patch platform for healthcare facilities’ use in diagnosing of sexually transmitted infections and cervical cancer.
Our products allow doctors and healthcare workers to appropriately test in a non-invasive way by providing faster, same-day results, and easier patient-centered diagnosing in the area of gynecologic health.
To date, no immediate diagnosis or combined diagnosis-treatment option for gynecologic malignancies such as sexually transmitted infections or gynecological cancers exists. This leaves patients vulnerable to greater health risks, such as HIV/AIDS, infertility, and the potential of other aggressive types of gynecologic cancers. In pregnant women, serious complications involving low birth weights and other health risks arise, as well. According to the World Health Organization, on a yearly basis there are 357 million new cases of four curable STIs and an estimated 530,000 cases of cervical cancer; of which 264,000 result in death each year.
A microneedle mediated intradermal diagnostic patch that will detect asymptomatic STIs and gynecologic cancers is of utmost need in our rapidly evolving globalized world. The physical, psychological and social consequences of sexual and reproductive health compromise rigorously the quality of life of those ill and at risk. We envision a world in which curable and treatable maladies can be detected before causing irreparable damage.
Meet the dermadiagnostics team!
diapatch™ screens for—
Seamless and effortless integration into busy, modern lifestyles, allowing for streamlined, higher quality patient care
non-invasive and accurate diagnosis
Faster, more accurate diagnosis
Non-invasive approach for easier workflow and patient care
Same-day results for appropriate patient triaging for follow-up procedures and treatment
WeWork West 6th
221 W 6th St.
Austin, TX 78701
ACC Bioscience Incubator
6101 Airport Blvd.
Austin, TX 78752
Our Phone No.